Other News To Note
Thursday, November 17, 2011
Aldagen Inc., of Durham, N.C., published a paper in the Journal of Stem Cell Research & Therapy describing the mechanisms by which its cell therapy products promoted formation of new blood vessels in ischemic tissues. The products induced expression of angiogenic genes encoding soluble growth factors, regulatory molecules and extracellular molecules that protect endothelial tubules from hypoxia-induced damage. Aldagen has clinical-stage programs targeting ischemia in the heart, brain and limbs.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.